AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2015
Aug 18, 2015
34931_dirs_2015-08-18_fe2d6702-ef63-484d-a415-48a12e809723.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2015-08-17
Reporting Person: Mazzo David J (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-17 | Common Stock, par value $0.001 per share | P | 20000 | $1.3961 | Acquired | 259543 | Direct |